Manufacturing - Specialty Pharma

Laprophan Group, one of Morocco's leading pharmaceutical groups, has completed the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company generating annual revenues...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction...

France-based Servier, an independent international pharmaceutical group governed by a foundation, is to acquire sevasemten and the muscular dystrophy business of Edgewise Therapeutics, a US-based muscle disease...

A consortium of funds led by CVC and GBL have entered into binding agreements for the launch of a voluntary cash tender offer for...

CellCentric, a clinical-stage biotechnology company, has completed an oversubscribed US$220m Series D financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management...

Angelini Pharma, the Italy-based international pharmaceutical company and part of the Angelini Industries Group, is entering the US market with the acquisition of Nasdaq-listed...

Atlas Health, a private equity fund established to invest in European Healthcare companies, has held an oversubscribed final close of its debut fund, Atlas...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, is to acquire Candid Therapeutics, a US-based privately held clinical-stage biotechnology...

Euronext-listed UCB, a Belgium-based global biopharmaceutical company focused on severe neurological and immunological conditions, has acquired the Patients Insights business of IMIDomics, a US-based...

Chiesi Group, an Italy-based, family-controlled, international research-focused biopharmaceutical group and certified B Corp, is acquiring Nasdaq-listed KalVista Pharmaceuticals, a global pharmaceutical company focused on...